Allion Healthcare, Inc. expected to Report Q3 2009 Results on November 9, 2009. This event was calculated by Capital IQ (Created on November 6, 2009).

Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Allion Healthcare Inc. for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by Allion's Board of Directors to sell all of the company's outstanding shares of common stock at a price of $6.60 per share in cash to H.I.G. Capital, LLC ('H.I.G.'). Stull, Stull & Brody has litigated many class actions for violations of securities laws and breaches of fiduciary duties on behalf of defrauded investors over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. The investigation concerns the price to be paid by H.I.G. to Allion shareholders and the process by which Allion's Board of Directors is addressing the transaction.

Allion Healthcare Inc. announced earnings results for the second quarter and six months ended June 30, 2009. For the quarter, the company reported operating income of $7,342,000 compared to $5,624,000 for the same period a year ago. Income before taxes for the period was $6,040,000 compared to $4,788,000 for the same period a year ago. Net income for the period was $3,182,000 or $0.11 diluted per share compared to $2,913,000 or $0.11 diluted per share for the same period a year ago. Net sales for the period were $99,658,000 compared to $86,430,000 for the same period a year ago. Adjusted net income for the period was $4,090,000 or $0.14 diluted per share compared to $2,913,000 or $0.11 diluted per share for the same period a year ago. Adjusted EBITDA for the period was $9,221,000 compared to $7,334,000 for the same period a year ago. For the six months, the company reported operating income of $14,424,000 compared to $3,393,000 for the same period a year ago. Income before taxes for the period was $12,215,000 compared to $2,772,000 for the same period a year ago. Net income for the period was $6,701,000 or $0.23 diluted per share compared to $1,643,000 or $0.08 diluted per share for the same period a year ago. Net sales for the period were $196,242,000 compared to $151,687,000 for the same period a year ago. Adjusted net income for the period was $7,964,000 or $0.27 diluted per share compared to $3,970,000 or $0.18 diluted per share for the same period a year ago. Adjusted EBITDA for the period was $17,960,000 compared to $9,928,000 for the same period a year ago. Net cash provided by operating activities for the period was $2,979,000 compared to $558,000 for the same period a year ago. Purchase of property and equipment for the period was $507,000 compared to $226,000 for the same period a year ago. The company reaffirms earnings guidance for the full year ending December 31, 2009. For the year, the company expects net sales to be between $400-$415 million. Adjusted earnings per diluted share is expected to be between $0.50-$0.52.